GSK Resolves Yet Another Zantac Legal Battle in California, Easing Concerns
San Francisco, California – Pharmaceutical company GlaxoSmithKline (GSK) has reached a settlement in yet another lawsuit regarding its popular heartburn medication, Zantac. The lawsuit was filed in California and alleged that the medication caused cancerous tumors in the plaintiff. GSK, based in the United Kingdom, has faced numerous lawsuits across the US concerning the potential link between Zantac and cancer. The settlement comes in the wake of recent studies that found the presence of a probable human carcinogen, NDMA, in ranitidine-based drugs like Zantac. The terms of the settlement were not disclosed, but GSK maintains … Read more